Trials / Completed
CompletedNCT02185222
Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
As recommended allowance of oral vitamine D are unable to ensure the recommended serum concentration of vitamine D, the purpose of this study is to show that a dose of vitamin D3 higher than the recommended allowance may slow the cognitive decline of patients with a memory complaint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cholecalciferol 100 000 UI | Study of superiority between Cholecalciferol high dose 100 000 UI versus placebo : one bulb per month during two years |
| DRUG | Placebo | Study of superiority between Cholecalciferol high dose 100 000 UI versus placebo : one bulb per month during two years |
Timeline
- Start date
- 2014-10-23
- Primary completion
- 2018-10-10
- Completion
- 2018-10-10
- First posted
- 2014-07-09
- Last updated
- 2020-11-04
Locations
11 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02185222. Inclusion in this directory is not an endorsement.